Table 2 Association between fibronectin expression and clinicopathological characteristics
From: Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
Clinical characteristics | Categories | FN1 low expression (n, %) | FN1 high expression (n, %) | P value |
|---|---|---|---|---|
Age | – | 69 (63–73) | 68 (63–73) | 0.618 |
Gender | Female | 46 (52.9) | 27 (52.9) | 0.994 |
Tumor size | ≦2 cm | 21 (24.1) | 2 (3.9) | 0.002 |
> 2 cm | 66 (75.9) | 49 (96.1) | ||
T stage | T1 | 17 (19.5) | 2 (3.9) | 0.020 |
T2 | 56 (64.4) | 36 (70.6) | ||
T3 | 13 (14.9) | 13 (25.5) | ||
T4 | 1 (1.1) | 0 (0) | ||
N stage | N0 | 25 (28.7) | 9 (18.0) | 0.009 |
N1 | 38 (43.7) | 14 (28.0) | ||
N2 | 24 (27.6) | 27 (54.0) | ||
Tumor differentiation | Poor/anaplastic | 51 (58.6) | 31 (62.0) | 0.698 |
AJCC stage, eighth edition | I-II | 62 (71.3) | 23 (46.0) | 0.003 |
III | 25 (28.7) | 27 (54.0) | ||
Resection margin | R1 | 33 (37.9) | 20 (39.2) | 0.881 |
Adjuvant chemotherapy | yes | 65 (78.3) | 46 (92.0) | 0.040 |